Medpace Holdings, Inc. Liability for Uncertainty in Income Taxes, Noncurrent
Medpace Holdings, Inc. (MEDP) had Liability for Uncertainty in Income Taxes, Noncurrent of $22.70 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:LiabilityForUncertainTaxPositionsNoncurrent · last filed 2026-02-10
- 2025-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $22.70M.
- 2024-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $20.30M.
- 2023-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $16.20M.
- 2022-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $12.70M.
| Period end | Liability for Uncertainty in Income Taxes, Noncurrent |
|---|---|
| 2025-12-31 | $22.70M 10-K · filed 2026-02-10 |
| 2024-12-31 | $20.30M 10-K · filed 2026-02-10 |
| 2023-12-31 | $16.20M 10-K · filed 2025-02-11 |
| 2022-12-31 | $12.70M 10-K · filed 2024-02-13 |
| 2021-12-31 | $11.00M 10-K · filed 2023-02-14 |
| 2020-12-31 | $8.60M 10-K · filed 2022-02-15 |
| 2019-12-31 | $8.20M 10-K · filed 2021-02-16 |
| 2018-12-31 | $7.20M 10-K · filed 2020-02-25 |
| 2017-12-31 | $5.90M 10-K · filed 2019-02-26 |
| 2016-12-31 | $4.30M 10-K · filed 2018-02-27 |
| 2015-12-31 | $1.80M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |